David K Imagawa

Title: David K Imagawa: Innovator in Medical Therapies

Introduction

David K Imagawa is a notable inventor based in Orange, California. He has made significant contributions to the field of medical therapies, particularly in cancer treatment and organ transplantation. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is focused on chemoembolization agents. This therapy combines the therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries that provide blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent used in this process is an anti-cancer drug. Another significant patent involves the use of perillyl alcohol in organ transplantation. This invention utilizes perillyl alcohol and its monoterpene derivatives, either alone or in combination with existing immunosuppressive agents, such as cyclosporine A and azathioprine. This method aims to reduce allograft rejection in organ transplant patients.

Career Highlights

David K Imagawa has worked with reputable institutions, including the University of California and Bruin Biosciences, Inc. His innovative approaches in medical therapies have garnered attention in the scientific community.

Collaborations

Throughout his career, David has collaborated with notable individuals such as Si Ming-Sing and James Na. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

David K Imagawa is a distinguished inventor whose work in medical therapies showcases his commitment to improving patient outcomes. His innovative patents in chemoembolization and organ transplantation highlight his significant contributions to the field.